tradingkey.logo

Scienture Holdings Inc

SCNX
View Detailed Chart
0.798USD
-0.020-2.44%
Market hours ETQuotes delayed by 15 min
12.88MMarket Cap
LossP/E TTM

Scienture Holdings Inc

0.798
-0.020-2.44%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.44%

5 Days

-19.37%

1 Month

-7.85%

6 Months

-16.07%

Year to Date

-86.81%

1 Year

-90.16%

View Detailed Chart

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Despite an average stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Scienture Holdings Inc's Score

Industry at a Glance

Industry Ranking
128 / 159
Overall Ranking
466 / 4616
Industry
Pharmaceuticals

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Scienture Holdings Inc Highlights

StrengthsRisks
Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Growing
The company is in a growing phase, with the latest annual income totaling USD 136.64K.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is -0.06, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 322.69K shares, increasing 23.55% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 14.57K shares of this stock.

Scienture Holdings Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Scienture Holdings Inc Info

Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Ticker SymbolSCNX
CompanyScienture Holdings Inc
CEODr. Narasimhan Mani
Website
KeyAI